BRASKEM SA (BAK) Form 6-K — May 14, 2026
Braskem S.A. reported a Recurring EBITDA of US$192 million in the first quarter of 2026, a 76% increase from the fourth quarter of 2025. This significant improvement is primarily attributed to the positive impact on COGS from the increase in the Special Regime for the Chemical Industry (REIQ) and the reduction in other recurring expenses. The company's net income attributable to shareholders in 1Q26 was US$275 million, a substantial increase from the previous quarter.
Key figures
- Eps
- 0
- Eps Beat
- 0
- Revenue
- 0
- Net Income
- US$275 million (R$1.4 billion)
- Total Debt
- US$12,046 million
- Debt Amount
- US$9.4 billion
- Revenue Yoy
- 0
- Total Assets
- 0
- Cash Position
- R$1.158 billion (US$828 million)
- Deal Value Usd
- 0
- Interest Rate
- +6.34% p.a.
- Gross Proceeds
- 0
- Offering Price
- 0
- Shares Offered
- 0
- Shares Outstanding
- 0
- Cogs Impact
- US$32 million (R$169 million)
- Cash Generation
- R$5.1 billion
- Recurring EBITDA
- US$192 million (R$1,006 million)
- Alagoas Provision Balance
- R$3,367 million
- Operating Cash Consumption
- R$3.2 billion
- Recurring Cash Consumption
- R$4.6 billion
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.